Additionally, the inclusion of leptin in a conventional risk model (including age, sex, BMI, LVEF, and presence of diabetes) significantly improved the prediction of MACE in patients with stable CAD (C-index 0.81 vs. 0.78) [26]. The gene discussed is LEP; the disease is diabetes mellitus.